NeuroscienceGliaPeer-reviewed
Aberrant Molecular Myelin Architecture in Charcot-Marie-Tooth Disease Type 1A and Hereditary Neuropathy with Liability to Pressure Palsies
Kathryn R. Moss, Marvis Ayoola Arowolo, Dave R. Gutierrez, Ahmet Höke
This study identifies molecular myelin architecture disruptions in CMT1A and HNPP models, linking PMP22 dosage to myelin defects and disease pathogenesis.